Provided by Tiger Trade Technology Pte. Ltd.

IO Biotech, Inc.

0.3728
+0.02286.51%
Post-market: 0.3603-0.0125-3.35%19:58 EST
Volume:2.73M
Turnover:1.01M
Market Cap:26.82M
PE:-0.28
High:0.3977
Open:0.3601
Low:0.3438
Close:0.3500
52wk High:2.79
52wk Low:0.2053
Shares:71.95M
Float Shares:31.16M
Volume Ratio:0.87
T/O Rate:8.75%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3356
EPS(LYR):-1.4494
ROE:-240.48%
ROA:-88.58%
PB:29.44
PE(LYR):-0.26

Loading ...

IO Biotech launches strategic review amid major restructuring

TIPRANKS
·
Jan 31

IO Biotech Inc - Expects One-Time Charges of $2.4 Mln to $2.6 Mln, During Q1 2026 - SEC Filing

THOMSON REUTERS
·
Jan 31

IO Biotech Cuts Workforce Amid Strategic Review

Reuters
·
Jan 30

IO Biotech Inc - Announces Significant Workforce Reduction

THOMSON REUTERS
·
Jan 30

IO Biotech Shares Fall After Piper Sandler Downgrade

MT Newswires Live
·
Jan 27

IO Biotech Cut to Neutral From Overweight by Piper Sandler

Dow Jones
·
Jan 27

Piper Sandler Downgrades IO Biotech to Neutral From Overweight, Adjusts Price Target to $0.50 From $3

MT Newswires Live
·
Jan 26

IO Biotech downgraded to Neutral from Overweight at Piper Sandler

TIPRANKS
·
Jan 24

NASD Most Active Issues

Dow Jones
·
Jan 24

BRIEF-Io Biotech Announces Exploration Of Strategic Alternatives

Reuters
·
Jan 21

IO Biotech announces exploration of strategic alternatives

TIPRANKS
·
Jan 21

IO Biotech Announces Exploration of Strategic Alternatives

THOMSON REUTERS
·
Jan 21

IO Biotech Inc - Evaluating Further Reduction-in-Force to Cut Expenses

THOMSON REUTERS
·
Jan 21

Morgan Stanley Downgrades IO Biotech to Underweight, Price Target is $0.36

MT Newswires Live
·
Jan 08

IO Biotech Faces Nasdaq Delisting Risk Over Minimum Bid Price Compliance

Reuters
·
Dec 20, 2025

IO Biotech Reports Five-Year Survival Data for IO102-IO103 Vaccine in Metastatic Melanoma Trial

Reuters
·
Dec 16, 2025

IO Biotech Announces Publication of Five-Year Clinical Outcomes of Phase 1/2 Trial in Nature Communications

THOMSON REUTERS
·
Dec 16, 2025

IO Biotech Announces Participation in Upcoming December Investor Conferences

GlobeNewswire
·
Nov 26, 2025

IO Biotech Announces Resignation of Chief Accounting Officer

TIPRANKS
·
Nov 22, 2025

IO Biotech Appoints CFO Amy Sullivan as Principal Accounting Officer

Reuters
·
Nov 22, 2025